KALA BIO KALA Stock
KALA BIO Price Chart
KALA BIO KALA Financial and Trading Overview
| KALA BIO stock price | 7.2 USD |
| Previous Close | 14.11 USD |
| Open | 14.11 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 14.04 - 14.82 USD |
| 52 Week Range | 3.54 - 56.72 USD |
| Volume | 68.07K USD |
| Avg. Volume | 165.46K USD |
| Market Cap | 34.6M USD |
| Beta (5Y Monthly) | -1.559154 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -17.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32 USD |
KALA Valuation Measures
| Enterprise Value | 4.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3601108 |
| PEG Ratio (5 yr expected) | -0.02 |
| Price/Sales (ttm) | 13.728652 |
| Price/Book (mrq) | 1.4499458 |
| Enterprise Value/Revenue | 1.678 |
| Enterprise Value/EBITDA | -0.07 |
Trading Information
KALA BIO Stock Price History
| Beta (5Y Monthly) | -1.559154 |
| 52-Week Change | -25.038% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 56.72 USD |
| 52 Week Low | 3.54 USD |
| 50-Day Moving Average | 15.7 USD |
| 200-Day Moving Average | 13.66 USD |
KALA Share Statistics
| Avg. Volume (3 month) | 165.46K USD |
| Avg. Daily Volume (10-Days) | 120.41K USD |
| Shares Outstanding | 2.35M |
| Float | 1.99M |
| Short Ratio | 1.47 |
| % Held by Insiders | 9.34% |
| % Held by Institutions | 25.26% |
| Shares Short | 149.83K |
| Short % of Float | 7.07% |
| Short % of Shares Outstanding | 6.37% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2403.61% |
| Gross Margin | 29.16% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.19% |
| Return on Equity (ttm) | -289.77% |
Income Statement
| Revenue (ttm) | 2.52M USD |
| Revenue Per Share (ttm) | 1.51 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.33M USD |
| EBITDA | -60114000 USD |
| Net Income Avi to Common (ttm) | -26336000 USD |
| Diluted EPS (ttm) | -14.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 63.64M USD |
| Total Cash Per Share (mrq) | 27.09 USD |
| Total Debt (mrq) | 33.27M USD |
| Total Debt/Equity (mrq) | 141.81 USD |
| Current Ratio (mrq) | 6.95 |
| Book Value Per Share (mrq) | 10.159 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64503000 USD |
| Levered Free Cash Flow (ttm) | -36567500 USD |
Profile of KALA BIO
| Country | United States |
| State | MA |
| City | Arlington |
| Address | 1167 Massachusetts Avenue |
| ZIP | 02476 |
| Phone | 781 996 5252 |
| Website | https://www.kalarx.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.
Q&A For KALA BIO Stock
What is a current KALA stock price?
KALA BIO KALA stock price today per share is 7.2 USD.
How to purchase KALA BIO stock?
You can buy KALA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for KALA BIO?
The stock symbol or ticker of KALA BIO is KALA.
Which industry does the KALA BIO company belong to?
The KALA BIO industry is Drug Manufacturers-Specialty & Generic.
How many shares does KALA BIO have in circulation?
The max supply of KALA BIO shares is 2.82M.
What is KALA BIO Price to Earnings Ratio (PE Ratio)?
KALA BIO PE Ratio is now.
What was KALA BIO earnings per share over the trailing 12 months (TTM)?
KALA BIO EPS is -17.35 USD over the trailing 12 months.
Which sector does the KALA BIO company belong to?
The KALA BIO sector is Healthcare.
KALA BIO KALA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}